News | November 07, 2006

New Software Provides Easy ICD Programming

New tachycardia software for the Merlin Patient Care System by St. Jude Medical has received FDA approval. The software upgrade utilizes a state-of-the-art computer to program and interrogate cardiac rhythm management devices like pacemakers and implantable cardioverter defibrillators (ICDs).

The Merlin system extends the benefits of the previously released Merlin graphical user interface (FDA approved in April) to both St. Jude Medical pacemaker and ICD products. It supports current and previous generation devices and is one of more than 20 new cardiac rhythm management products being introduced by St. Jude Medical this year. With it, physicians can quickly and easily make changes to device therapy using an LCD touch-screen.

For more information visit www.sjm.com.


Related Content

News | Implantable Cardioverter Defibrillator (ICD)

March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...

Home March 07, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...

Home February 17, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

Home August 29, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 18, 2022 — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients ...

Home August 18, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

July 21, 2022 — The global automated external defibrillators market size was valued at USD 717 million in 2021. It is ...

Home July 22, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

June 10, 2022 — Setting a lower price to enter a competitive market with established brand leaders is a common ...

Home June 10, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)
May 2, 2022 – High-risk patients who need defibrillators to prevent cardiac arrest can experience fewer complications ...
Home May 02, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)
February 14, 2022 — Philips, a global leader in health technology, is supporting the American Heart Association’s multi ...
Home February 14, 2022
Home
Feature | Implantable Cardioverter Defibrillator (ICD) | By Dave Fornell, Editor

February 2, 2020 — The U.S. Food and Drug Administration (FDA) has identified a recent recall of the Boston Scientific ...

Home February 02, 2021
Home
Subscribe Now